Alzamend Neuro (ALZN) EBITDA (2022 - 2026)
Alzamend Neuro (ALZN) recorded EBITDA of -$3 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$2.67 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) EBITDA (2022 - 2026) Analysis & Trends
On a TTM basis, Alzamend Neuro's EBITDA came in at -$8.98 million as of Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it came in at -$8.66 million.
- Across earlier fiscal years, EBITDA came in at -$4.45 million in FY2025, -$9.89 million in FY2024, -$14.85 million in FY2023 and -$12.32 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly EBITDA since fiscal Q1 2024.
- Per Business Quant, the preceding three fiscal quarters came in at -$2.84 million (Q4 2026), -$2.17 million (Q3 2026) and -$970,424 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | -3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -3.00 Mn |
| Apr 30, 2026 | -2.84 Mn |
| Jan 31, 2026 | -2.17 Mn |
| Oct 31, 2025 | -970,424.00 |
| Jul 31, 2025 | -2.67 Mn |
| Apr 30, 2025 | -1.13 Mn |
| Jan 31, 2025 | -1.02 Mn |
| Oct 31, 2024 | -1.35 Mn |
| Jul 31, 2024 | -940,434.00 |
| Apr 30, 2024 | -837,379.00 |
| Jan 31, 2024 | -2.65 Mn |
| Oct 31, 2023 | -2.89 Mn |
| Jul 31, 2023 | -3.51 Mn |
| Apr 30, 2023 | -3.30 Mn |
| Jan 31, 2023 | -5.42 Mn |
| Oct 31, 2022 | -3.10 Mn |
| Jul 31, 2022 | -3.03 Mn |
API Access
Alzamend Neuro EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();